Immupharma PLC Holding(s) in Company (6514M)
January 21 2016 - 12:33PM
UK Regulatory
TIDMIMM TIDMAV.
RNS Number : 6514M
Immupharma PLC
21 January 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Immupharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- -----------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
----------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------------------------------------
Other (please CHANGE IN NATURE: RETURN OF LOANED
specify): SHARES
----------------------------------------------------------- ---------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- ---------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 232,080*
Chase (GA Group) Nominees
Limited 6,977,654*
*denotes direct interest
Chase (GA Group) Nominees
Limited 373,991
Chase Nominees Limited 150,841
Vidacos Nominees Limited 406,282
------------------------------------------------------------- ---------------------------------------------
5. Date of the transaction 19 January 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- ---------------------------------------------
6. Date on which issuer 20 January 2016
notified:
------------------------------------------------------------- ---------------------------------------------
7. Threshold(s) that is/are 7% to 8% Change at Direct
crossed or Interest Level (Box 8A)
reached: (vi, vii)
------------------------------------------------------------- ---------------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after
of to the triggering the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------------- -------------------------------- -----------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
------------------- ------------------- ----------- ---------- --------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------------- ------------------- ----------- ---------- ---------- --------- ------- ---------
Ordinary
Shares
GB0033711010 8,140,848* 8,140,848* 8,140,848 7,209,734 931,114 8.14% 1.05%
------------------- ----------- ---------- ---------- --------- ------- ---------
*Includes right to recall loaned shares (168,000)
------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------- ------------------- ----------------------- --------------------- ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
8,140,848 9.19%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
---------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
--------------------------------------------- ----------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
--------------------------------------------- ----------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
--------------------------------------------- ----------------------------------
13. Additional information: Figures are based the total
number of voting rights of
88,622,463 as per the recent
Additional Listing - Conditional
(MORE TO FOLLOW) Dow Jones Newswires
January 21, 2016 12:33 ET (17:33 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024
